Company announcements

Dealing in securities by executive directors and prescribed officers: deferred share awards

November 04, 2021

---

In compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information is disclosed: DEALING IN SECURITIES BY EXECUTIVE DIRECTORS AND PRESCRIBED OFFICERS: DEFERRED SHARE AWARDS

Johannesburg, 4 November 2021. In line with the provisions of the 2018 Harmony Deferred Share Plan, executive directors and prescribed officers of Harmony were awarded deferred shares on 20 September 2021 based on the 5-day volume weighted average price of R 46.79 per ordinary share and accepted these awards on 3 November 2021.

The following transaction are disclosed in relation to the deferred share awards:

1. Name of director:	PW Steenkamp (Chief Executive Officer)
Nature of transaction:	Off market award of deferred shares
Periods of vesting:	Deferred shares vest in equal tranches over a five year period.
Class of securities:	Deferred ordinary shares
Number of deferred shares awarded:	222 281
Total value of shares awarded:	R10 400 527.99
Nature and extent of director’s interest:	Direct beneficial

2. Name of director:	B Lekubo (Financial Director)
Nature of transaction:	Off market award of deferred shares
Periods of vesting:	Deferred shares vest in equal tranches over a five year period.
Class of securities:	Deferred ordinary shares
Number of deferred shares awarded:	132 550
Total value of shares awarded:	R6 202 014.50
Nature and extent of director’s interest:	Direct beneficial

3. Name of director:	HE Mashego (Executive Director)
Nature of transaction:	Off market award of deferred shares
Periods of vesting:	Deferred shares vest in equal tranches over a five year period.
Class of securities:	Deferred ordinary shares
Number of deferred shares awarded:	105 739
Total value of shares awarded:	R4 947 527.81
Nature and extent of director’s interest:	Direct beneficial

4. Name of prescribed officer:	BB Nel
Nature of transaction:	Off market award of deferred shares
Periods of vesting:	Deferred shares vest in equal tranches over a five year period.
Class of securities:	Deferred ordinary shares
Number of deferred shares awarded:	108 738
Total value of shares awarded:	R5 087 851.02
Nature and extent of Prescribed officer’s interest:	Direct beneficial

5.Name of prescribed officer:	VP Tobias
Nature of transaction:	Off market award of deferred shares
Periods of vesting:	Deferred shares vest in equal tranches over a five year period.
Class of securities:	Deferred ordinary shares
Number of deferred shares awarded: Total value of shares awarded:	115 031 R5 382 300.49
Nature and extent of Prescribed officer’s interest:	Direct beneficial

6. Name of prescribed officer:	JJ van Heerden
Nature of transaction:	Off market award of deferred shares
Periods of vesting:	Deferred shares vest in equal tranches over a five year period.
Class of securities:	Deferred ordinary shares
Number of deferred shares awarded:	123 771
Total value of shares awarded:	R5 791 245.09
Nature and extent of Prescribed officer’s interest:	Direct beneficial

7. Name of prescribed officer:	MP van der Walt
Nature of transaction:	Off market award of deferred shares
Periods of vesting:	Deferred shares vest in equal tranches over a five year period.
Class of securities:	Deferred ordinary shares
Number of deferred shares awarded:	98 701
Total value of shares awarded:	R4 618 219.79
Nature and extent of Prescribed officer’s interest:	Direct beneficial

8. Name of company secretary:	SS Mohatla
Nature of transaction:	Off market award of deferred shares
Periods of vesting:	Deferred shares vest in equal tranches over a three year period.
Class of securities:	Deferred ordinary shares
Number of deferred shares awarded:	22 384
Total value of shares awarded:	R1 047 347.36
Nature and extent of company secretary’s interest:	Direct beneficial

Prior clearance was obtained in respect of the above dealings by the directors.

For more details contact:

Jared Coetzer
Head of Investor Relations
+27 (0) 82 746 4120

Johannesburg, South Africa
4 November 2021

Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited